| Cardiovascular Risk Management |
1 |
1 |
| Depression |
0 |
1 |
| Antidepressant drug |
0 |
0.9 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.23 |
| Cerebrovascular Disease |
0 |
0.2 |
| Primary Care |
0 |
0.2 |
| Hypertension |
0 |
0.19 |
| Cerebrovascular Accident |
0 |
0.18 |
| Coronary Artery Disease (CAD) |
0 |
0.11 |
| Cardiovascular disease |
0 |
0.08 |
| Disability |
0 |
0.08 |
| Exercise |
0 |
0.08 |
| Hand |
0 |
0.08 |
| NHS |
0 |
0.08 |
| Socioeconomics |
0 |
0.08 |
| UK Site Content |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.07 |
| Biomarker |
0 |
0.04 |
| Body Mass Index |
0 |
0.04 |
| Brain |
0 |
0.04 |
| Child |
0 |
0.04 |
| Fellowship |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Heart |
0 |
0.04 |
| Mood Disorders |
0 |
0.04 |
| Psychopharmacology |
0 |
0.04 |
| Psychotropic Drugs |
0 |
0.04 |
| Weakness |
0 |
0.04 |